Paraneoplastic vasculitis of the peripheral nervous system

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

There are 30 patients with paraneoplastic vasculitic neuropathy in the literature. The disorder typically presents in older men with subacute and occasionally painful neuropathy and a clinical and electrodiagnostic pattern of mononeuropathy multiplex or axonal sensorimotor polyneuropathy. The erythrocyte sedimentation rate and cerebrospinal fluid protein content and cell count are typically elevated, with more than one-third of patient manifesting circulating antibodies to Hu. The commonest associated malignancies are small cell lung cancer and lymphoma although other cancers have been noted. Sural nerve biopsy typically reveals microvasculitis as may muscle tissue in addition to neurogenic features. The vasculitic disorder may be systemic or nonsystemic. Treatment is directed toward the underlying malignancy as well as immune modulatory and immunosuppressant medication alone or in combination for the neuropathy and vasculitic process, with up to one-half of patients demonstrating clinical improvement. Although uncommon, unsuspected patients may continue to worsen and suffer excess morbidity and mortality due to the underlying cancer and neuropathic disorder.

Original languageEnglish (US)
Title of host publicationNervous System Vasculitis and Treatment
PublisherNova Science Publishers, Inc.
Pages195-203
Number of pages9
Volume2
ISBN (Print)9781634631396, 9781634631129
StatePublished - Jan 1 2014

Fingerprint

Peripheral Nervous System
Vasculitis
Paraneoplastic Polyneuropathy
Neoplasms
Mononeuropathies
Cerebrospinal Fluid Proteins
Sural Nerve
Polyneuropathies
Blood Sedimentation
Small Cell Lung Carcinoma
B-Cell Chronic Lymphocytic Leukemia
Immunosuppressive Agents
Cell Count
Morbidity
Biopsy
Muscles
Mortality
Antibodies
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Phillips, L., & Vernino, S. (2014). Paraneoplastic vasculitis of the peripheral nervous system. In Nervous System Vasculitis and Treatment (Vol. 2, pp. 195-203). Nova Science Publishers, Inc..

Paraneoplastic vasculitis of the peripheral nervous system. / Phillips, Lauren; Vernino, Steven.

Nervous System Vasculitis and Treatment. Vol. 2 Nova Science Publishers, Inc., 2014. p. 195-203.

Research output: Chapter in Book/Report/Conference proceedingChapter

Phillips, L & Vernino, S 2014, Paraneoplastic vasculitis of the peripheral nervous system. in Nervous System Vasculitis and Treatment. vol. 2, Nova Science Publishers, Inc., pp. 195-203.
Phillips L, Vernino S. Paraneoplastic vasculitis of the peripheral nervous system. In Nervous System Vasculitis and Treatment. Vol. 2. Nova Science Publishers, Inc. 2014. p. 195-203
Phillips, Lauren ; Vernino, Steven. / Paraneoplastic vasculitis of the peripheral nervous system. Nervous System Vasculitis and Treatment. Vol. 2 Nova Science Publishers, Inc., 2014. pp. 195-203
@inbook{f3352ebd0a0f4a74973b5497f2bf4f60,
title = "Paraneoplastic vasculitis of the peripheral nervous system",
abstract = "There are 30 patients with paraneoplastic vasculitic neuropathy in the literature. The disorder typically presents in older men with subacute and occasionally painful neuropathy and a clinical and electrodiagnostic pattern of mononeuropathy multiplex or axonal sensorimotor polyneuropathy. The erythrocyte sedimentation rate and cerebrospinal fluid protein content and cell count are typically elevated, with more than one-third of patient manifesting circulating antibodies to Hu. The commonest associated malignancies are small cell lung cancer and lymphoma although other cancers have been noted. Sural nerve biopsy typically reveals microvasculitis as may muscle tissue in addition to neurogenic features. The vasculitic disorder may be systemic or nonsystemic. Treatment is directed toward the underlying malignancy as well as immune modulatory and immunosuppressant medication alone or in combination for the neuropathy and vasculitic process, with up to one-half of patients demonstrating clinical improvement. Although uncommon, unsuspected patients may continue to worsen and suffer excess morbidity and mortality due to the underlying cancer and neuropathic disorder.",
author = "Lauren Phillips and Steven Vernino",
year = "2014",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781634631396",
volume = "2",
pages = "195--203",
booktitle = "Nervous System Vasculitis and Treatment",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Paraneoplastic vasculitis of the peripheral nervous system

AU - Phillips, Lauren

AU - Vernino, Steven

PY - 2014/1/1

Y1 - 2014/1/1

N2 - There are 30 patients with paraneoplastic vasculitic neuropathy in the literature. The disorder typically presents in older men with subacute and occasionally painful neuropathy and a clinical and electrodiagnostic pattern of mononeuropathy multiplex or axonal sensorimotor polyneuropathy. The erythrocyte sedimentation rate and cerebrospinal fluid protein content and cell count are typically elevated, with more than one-third of patient manifesting circulating antibodies to Hu. The commonest associated malignancies are small cell lung cancer and lymphoma although other cancers have been noted. Sural nerve biopsy typically reveals microvasculitis as may muscle tissue in addition to neurogenic features. The vasculitic disorder may be systemic or nonsystemic. Treatment is directed toward the underlying malignancy as well as immune modulatory and immunosuppressant medication alone or in combination for the neuropathy and vasculitic process, with up to one-half of patients demonstrating clinical improvement. Although uncommon, unsuspected patients may continue to worsen and suffer excess morbidity and mortality due to the underlying cancer and neuropathic disorder.

AB - There are 30 patients with paraneoplastic vasculitic neuropathy in the literature. The disorder typically presents in older men with subacute and occasionally painful neuropathy and a clinical and electrodiagnostic pattern of mononeuropathy multiplex or axonal sensorimotor polyneuropathy. The erythrocyte sedimentation rate and cerebrospinal fluid protein content and cell count are typically elevated, with more than one-third of patient manifesting circulating antibodies to Hu. The commonest associated malignancies are small cell lung cancer and lymphoma although other cancers have been noted. Sural nerve biopsy typically reveals microvasculitis as may muscle tissue in addition to neurogenic features. The vasculitic disorder may be systemic or nonsystemic. Treatment is directed toward the underlying malignancy as well as immune modulatory and immunosuppressant medication alone or in combination for the neuropathy and vasculitic process, with up to one-half of patients demonstrating clinical improvement. Although uncommon, unsuspected patients may continue to worsen and suffer excess morbidity and mortality due to the underlying cancer and neuropathic disorder.

UR - http://www.scopus.com/inward/record.url?scp=84961345366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961345366&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84961345366

SN - 9781634631396

SN - 9781634631129

VL - 2

SP - 195

EP - 203

BT - Nervous System Vasculitis and Treatment

PB - Nova Science Publishers, Inc.

ER -